Maternal Outcome In Eclamptic Patients Receiving Magnesium Sulphate As Anticonvulsant

Authors: Shaista Tabusum Abro, Fouzia Kashif, Irum Laghari, Afshan Bhatti, Shazia Shaikh.

1. CHANDKA MEDICAL COLLEGE LARKANA.
2. CHANDKA MEDICAL COLLEGE LARKANA.
3. CHANDKA MEDICAL COLLEGE LARKANA.
4. CHANDKA MEDICAL COLLEGE LARKANA.
5. CHANDKA MEDICAL COLLEGE LARKANA.

Volume 32 | Issue 2

Published: October 29, 2026

Abstract

The purpose of study was to analyze the effects of Magnesium sulphate(MgS04) by compare the number of patients develop fits before and after giving MgS04 and how this is safe at recommended doses for eclamptic patients by monitor the maternal mortality due to MgS04 complications. STUDY DESIGN : Descriptive cross sectional study based on observation of effects of MgS04. SETTING : Department of obstetrics/gynecology unit III Civil hospital Karachi DURATION : Collection of data over one year period between Nov: 2021 to Oct: 2023 SUBJECT : 32 Eclamptic patients. METHOD : All eclamptic patients whether booked or un-booked admitted through out patient department or emergency were giving MgS04 and no of patients developed fits after giving MgS04 evaluated, patients monitored for drugs related complications.MgS04 administered for 24hour after last fit or delivery, while patient’s Blood pressure, pulse, respiratory rate, tendon reflexes and urine output monitored half hourly. Recorded all complications related to MgS04. RESULTS : Our period of one year eclamptic patients registered were 32 (1.76%). A patients either with antepartum, intrapartum or postpartum eclampsia managed acutely by emergency measures.75% patients were unbooked while 25% booked.out of 32 patients 30 received MgS04 and maternal morbidity were observed in 12% of cases. During the period of study one maternal death(6.66%) occurred, Cause of death was cardio pulmonary arrest.Non of the patients developed fits after receiving MgSO4. The P value <.001 considereed as significant. CONCLUSION : We come to conclusion that using MgS04 found to be effective for fits control and decreased both maternal and fetal mortality.

Keywords: Eclampsia, maternal mortality,anticonvulsant,MgS04

DOI: (All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.)